DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
DYADIC INTERNATIONAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.38−0.03 (-7.35%)
Close on Oct 19, 2026
- Market cap
- $13.88M
- P/E (TTM)
- –
- Dividend yield
- –
Dyadic International statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Dyadic International | Industry median |
|---|---|---|
| Market Cap | $13.88M | $166.30M |
| Enterprise Value | $9.08M | $88.19M |
| PS Ratio | 3.65 | 3.65 |
Enterprise value
| Measure | Dyadic International | Industry median |
|---|---|---|
| EV / Sales | 2.39 | 2.51 |
Income (trailing twelve months)
| Measure | Dyadic International | Industry median |
|---|---|---|
| Revenue | $3.80M | $58.34M |
| Gross Profit | $617.62K | $105.94M |
| Operating Income | -$7.42M | -$21.40M |
| Net Income | -$7.62M | -$22.46M |
| EBITDA | -$7.42M | -$16.91M |
| EPS (Diluted) | -$0.23 | -$0.83 |
Margins
| Measure | Dyadic International | Industry median |
|---|---|---|
| Gross Margin | 16.2% | 52.9% |
| Operating Margin | -195.1% | -44.0% |
| Profit Margin | -200.5% | -40.2% |
| EBITDA Margin | -195.1% | -30.2% |
Returns
| Measure | Dyadic International | Industry median |
|---|---|---|
| Return on Assets (ROA) | -103.9% | -40.9% |
| Return on Capital Employed (ROCE) | -279.5% | -38.1% |
Growth
| Measure | Dyadic International | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -8.05% | 5.96% |
| Revenue Growth (3Y CAGR) | 1.79% | 2.25% |
| Revenue Growth (5Y CAGR) | 14.0% | 6.48% |
Balance sheet
| Measure | Dyadic International | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $4.80M | $61.43M |
| Net Cash (Debt) | $4.80M | $15.35M |
| Net Cash Per Share | $0.13 | $0.66 |
| Equity (Book Value) | -$2.39M | $49.09M |
| Book Value Per Share | -$0.07 | $1.37 |
| Tangible Book Value | -$2.39M | $23.52M |
| Working Capital | $2.52M | $76.81M |
Financial position
| Measure | Dyadic International | Industry median |
|---|---|---|
| Current Ratio | 1.65 | 3.34 |
| Quick Ratio | 1.57 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Dyadic International | Industry median |
|---|---|---|
| Operating Cash Flow | -$7.40M | -$12.35M |
Efficiency
| Measure | Dyadic International | Industry median |
|---|---|---|
| Asset Turnover | 0.52 | 0.39 |
| Revenue Per Employee | $760.45K | $404.87K |
| Profits Per Employee | -$1.52M | -$703.34K |
| Employee Count | 5 | 74 |
Dividends and yields
| Measure | Dyadic International | Industry median |
|---|---|---|
| Earnings Yield | -54.9% | -23.3% |
Shares
| Measure | Dyadic International | Industry median |
|---|---|---|
| Shares Outstanding | 36,438,700 | 58,127,000 |
| Shares Change (YoY) | 13.6% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 26,235,000 | 49,136,700 |
| Shares Held by Insiders | 28.0% | 11.6% |
| Shares Held by Institutions | 12.7% | 59.4% |
Scores
| Measure | Dyadic International | Industry median |
|---|---|---|
| Altman Z-Score | -22.66 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Dyadic International's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.